9 results on '"Choi, Seung Ho"'
Search Results
2. Clinical utility of 18F-FDG PET/CT for patients with recurrent head and neck squamous cell carcinoma.
- Author
-
Ha, Seung Cheol, Roh, Jong-Lyel, Kim, Jae Seung, Lee, Jeong Hyun, Choi, Seung-Ho, Nam, Soon Yuhl, and Kim, Sang Yoon
- Subjects
HEAD & neck cancer diagnosis ,CANCER relapse ,COMPUTED tomography ,DEOXY sugars ,METASTASIS ,HEAD & neck cancer ,RADIOPHARMACEUTICALS ,POSITRON emission tomography ,SQUAMOUS cell carcinoma ,PREDICTIVE tests ,CONTRAST media ,SALVAGE therapy ,PROGNOSIS - Abstract
Copyright of Acta Oto-Laryngologica is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2019
- Full Text
- View/download PDF
3. Clinical implications of nonspecific pulmonary nodules identified during the initial evaluation of patients with head and neck squamous cell carcinoma.
- Author
-
Kwon, Minsu, Lee, Sang, Lee, Yoon, Lee, Choong, Roh, Jong-Lyel, Choi, Seung-Ho, Nam, Soon, Kim, Sang, Lee, Sang Hoon, Lee, Yoon Se, Lee, Choong Wook, Nam, Soon Yuhl, and Kim, Sang Yoon
- Subjects
SQUAMOUS cell carcinoma ,PULMONARY nodules ,COMPUTED tomography ,PULMONARY artery ,LYMPH nodes ,PATIENTS ,CANCER ,HEAD tumors ,LUNG tumors ,NECK tumors ,REGRESSION analysis ,SURVIVAL analysis (Biometry) ,PREDICTIVE tests ,RETROSPECTIVE studies - Abstract
Objective: We aimed to identify the clinical implications of nonspecific pulmonary nodules (NPNs) detected in the initial staging workup for patients with head and neck squamous cell carcinoma (HNSCC).Methods: Medical records of patients who had been diagnosed and treated in our hospital were retrospectively analysed. After definite treatment, changes of NPNs detected on initial evaluation were monitored via serial chest computed tomography. The associations between NPNs and the clinicopathological characteristics of primary HNSCC were evaluated. Survival analyses were performed according to the presence of NPNs.Results: The study consisted of 158 (49.4%) patients without NPNs and 162 (50.6%) patients with NPNs. The cumulative incidence of probabilities of pulmonary malignancy (PM) development at 2 years after treatment were 9.0% and 6.2% in NPN-negative and NPN-positive patients, respectively. Overall and PM-free survival rates were not significantly different according to NPN status. Cervical lymph node (LN) involvement and a platelet-lymphocyte ratio (PLR) ≥126 increased the risk of PMs (both P <0.05).Conclusions: NPNs detected in the initial evaluation of patients with HNSCC did not predict the risk of pulmonary malignancies. Cervical LN involvement and PLR ≥126 may be independent prognostic factors affecting PM-free survival regardless of NPN status.Key Points: • We aimed to identify the clinical implications of nonspecific pulmonary nodules (NPNs). • NPNs in head and neck cancer patients do not lead to pulmonary malignancies (PMs). • NPNs are not associated with overall or PM-free survival (PMFS). • Cervical lymph node involvement is an independent prognostic factor affecting PMFS. • Platelet-lymphocyte ratio ≥126 is another predictor of PMFS regardless of NPN presence. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
4. Prognostic significance of standardized uptake value and metabolic tumour volume on F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
- Author
-
Kim, Ji, Oh, Jungsu, Roh, Jong-Lyel, Kim, Jae, Choi, Seung-Ho, Nam, Soon, and Kim, Sang
- Subjects
POSITRON emission tomography ,COMPUTED tomography ,SQUAMOUS cell carcinoma ,BIOMARKERS ,CANCER treatment ,MULTIVARIATE analysis ,PROPORTIONAL hazards models - Abstract
Purpose: Standardized uptake value (SUV) and metabolic tumour volume (MTV) measured by F-FDG PET/CT are emerging prognostic biomarkers in human solid cancers. However, their prognostic significance in oropharyngeal squamous cell carcinoma (OPSCC) has been investigated in only a few studies and with small cohorts. In the present study we evaluated the ability of SUV, MTV, and total lesion glycolysis (TLG) measured on pretreatment F-FDG PET/CT to predict recurrence and survival outcomes in OPSCC. Methods: The study included 221 patients with OPSCC who underwent pretreatment F-FDG PET/CT imaging and received definitive treatment at our tertiary referral centre. The PET imaging parameters SUV, SUV, MTV and TLG were measured in primary tumours with focal F-FDG uptake. Clinical and imaging variables significantly associated with overall survival (OS) and disease-free survival (DFS) were identified by univariate and multivariate analyses using the Cox proportional hazards model. Results: Overall 5-year OS and DFS rates were 72.0 % and 79.5 %, respectively, during a median follow-up of 61 months (range 18 - 122 months). The cut-off values of tumour SUV, SUV, MTV and TLG for prediction of DFS were 7.55, 6.80, 11.06 mL and 78.56 g, respectively. Univariate analyses showed that age >60 years, advanced tumour stage, and high tumour SUV, SUV, MTV and TLG were significantly associated with decreased OS and DFS ( P < 0.05 each). Age, tumour SUV and MTV remained independent variables for OS and DFS ( P < 0.05 each) in the multivariate analyses. Conclusion: SUV and MTV measured on pretreatment F-FDG PET/CT may be useful in predicting the clinical outcomes in OPSCC patients. Condensed abstract: This study investigated the clinical prognostic value of imaging parameters from pretreatment F-FDG PET/CT in 221 patients who underwent definitive treatment for oropharyngeal squamous cell carcinoma. High maximum standardized uptake value and metabolic tumour volume were independently associated with decreased disease-free and overall survival outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
- Author
-
Jung, Ah Ra, Roh, Jong-Lyel, Kim, Jae Seung, Kim, Sung-Bae, Choi, Seung-Ho, Nam, Soon Yuhl, and Kim, Sang Yoon
- Subjects
- *
CANCER relapse , *HEAD & neck cancer treatment , *CANCER treatment , *ADIPOSE tissues , *BLOOD protein disorders , *BODY composition , *COMPUTED tomography , *DEOXY sugars , *LONGITUDINAL method , *LUMBAR vertebrae , *MULTIVARIATE analysis , *HEAD & neck cancer , *ONCOGENES , *RADIOPHARMACEUTICALS , *SQUAMOUS cell carcinoma , *STATISTICS , *SURVIVAL , *TUMOR classification , *MULTIPLE regression analysis , *BODY mass index , *TREATMENT effectiveness , *SARCOPENIA , *PROPORTIONAL hazards models , *LEAN body mass , *SKELETAL muscle , *PROGNOSIS , *CANCER risk factors ,MORTALITY risk factors - Abstract
Head and neck squamous cell carcinoma (HNSCC) is commonly associated with a high risk of malnutrition and sarcopenia, related to adverse clinical outcomes. This study evaluated the prognostic values of body composition on recurrence and survival in patients with advanced-stage HNSCC. This study prospectively enrolled 258 consecutive patients with definitive treatments for advanced-stage HNSCC. For the determination of sarcopenia, the cross-sectional area of the skeletal muscles (SMs) was measured at the level of the third lumbar vertebra on the computed tomography images of whole-body 18F-fluorodeoxyglucose positron-emission tomography/computed tomography before and after treatments. Univariate and multivariate Cox proportional hazards regression analyses were performed to identify the prognostic factors of disease-free survival (DFS) and overall survival (OS). Pretreatment and post-treatment diminished SM masses (sarcopenia) were found in 17 (6.6%) and 32 (12.4%) of 258 included patients, respectively. All values of body composition, SM index, visceral fat area, lean body mass, fat mass and body mass index significantly decreased after treatment (all P < 0.05). Multivariable analyses showed that age, Charlson comorbidity index, pretreatment and post-treatment sarcopenia, pretreatment hypoalbuminaemia, p16 status and tumour site remained the independent variables predictive of DFS and OS outcomes (all P < 0.05). Patients with sarcopenia before or after treatment had about threefold increased risk of overall recurrence or death. Diminished SM mass may predict recurrence and survival after definitive treatments in patients with advanced-stage HNSCC. • Skeletal muscle mass was measured from computed tomography images at L3 before and after treatment. • Pretreatment and post-treatment sarcopenia were found in 6.6% and 12.4%, respectively. • Most body composition parameters significantly decreased after treatment. • Sarcopenia is the independent risk factor for disease-free and overall survival after treatment. • Sarcopenia was associated with about threefold increased risk of overall recurrence or death. Condensed Abstract : This study evaluated the prognostic values of body composition on recurrence and survival in 258 patients with advanced-stage head and neck squamous cell carcinoma. Sarcopenia was the independent risk factor for poorer disease-free and overall survival outcomes after definitive treatments, showing about threefold increased risk of overall recurrence or death. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
6. Chest radiography or chest CT plus head and neck CT versus 18F-FDG PET/CT for detection of distant metastasis and synchronous cancer in patients with head and neck cancer.
- Author
-
Kim, Yehree, Roh, Jong-Lyel, Kim, Jae Seung, Lee, Jeong Hyun, Choi, Seung-Ho, Nam, Soon Yuhl, and Kim, Sang Yoon
- Subjects
- *
WHOLE body imaging , *HEAD & neck cancer , *METASTASIS , *RADIOGRAPHY , *SQUAMOUS cell carcinoma , *NECK , *BONE tumors , *COMPUTED tomography , *DEOXY sugars , *HEAD tumors , *LIVER tumors , *LONGITUDINAL method , *LUNG tumors , *MULTIPLE tumors , *NECK tumors , *RADIOPHARMACEUTICALS , *X-rays - Abstract
Objectives: Current guidelines recommend chest computed tomography (CT) with locoregional CT/magnetic resonance imaging for patients with head and neck squamous cell carcinoma (HNSCC), and 18F-fluorodeoxyglucose (FDG) positron-emission tomography (PET)/CT is suggested for stage III-IV patients. However, whole body screening with 18F-FDG PET/CT may provide better detection of distant metastases and synchronous cancer than conventional imaging. We evaluated the utility of 18F-FDG PET/CT in detecting distant metastasis and synchronous cancer.Methods: This prospective study enrolled 740 consecutive patients with previously untreated HNSCC diagnosed between September 2010 and December 2015. Synchronous cancer was histologically confirmed and distant metastases were confirmed by biopsy or serial imaging follow-ups. McNemar test was used to compare the true-positive detection rates of chest radiography (CXR) + head and neck CT (hnCT) (A) versus 18F-FDG PET/CT (C) and chest CT + hnCT (B) versus 18F-FDG PET/CT.Results: Distant metastases and synchronous cancer were found in 23 (3.1%) and 55 (7.4%) patients, respectively. A, B, and C detected distant metastases in 10 (1.3%), 19 (2.6%), and 21 (2.8%) patients, respectively. The absolute differences were 1.5% (A versus C, P = 0.003) and 0.3% (B versus C, P = 0.687). A, B, and C detected synchronous cancer in 15 (2.0%), 22 (2.9%), and 36 (4.9%) patients, respectively. The absolute differences were 2.8% (A versus C, P < 0.001) and 1.4% (B versus C, P = 0.013).Conclusions: 18F-FDG PET/CT detected more distant metastases and synchronous cancer than CXR + hnCT and more synchronous cancer than chest CT + hnCT. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
7. 18F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer.
- Author
-
Kim, Shin-Ae, Roh, Jong-Lyel, Kim, Jae Seung, Lee, Jeong Hyun, Lee, Sang Hoon, Choi, Seung-Ho, Nam, Soon Yuhl, and Kim, Sang Yoon
- Subjects
- *
CANCER relapse , *EVALUATION of diagnostic imaging , *NECK tumors , *COMBINED modality therapy , *COMPUTED tomography , *HEAD tumors , *PROBABILITY theory , *SQUAMOUS cell carcinoma , *SURVIVAL analysis (Biometry) , *POSITRON emission tomography , *LOGISTIC regression analysis , *DATA analysis , *PROPORTIONAL hazards models , *RECEIVER operating characteristic curves , *SURGERY , *DIAGNOSIS - Abstract
Background Posttreatment detection of recurrence may lead to salvage treatment and prognostic prediction in patients with head and neck squamous cell carcinoma (HNSCC). We evaluated the diagnostic and prognostic values of 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography (PET)/computed tomography (CT) after definitive treatment of HNSCC. Methods This prospective study included 278 consecutive patients who underwent curative surgery ( n = 143, 51.4%) or definitive radiotherapy/chemoradiotherapy ( n = 135, 48.6%) for previously untreated HNSCC. The patients were regularly followed up and evaluated by 18 F-FDG PET/CT, head and neck CT/magnetic resonance imaging (MRI), and chest CT at regular intervals after treatment. The imaging interpretations were compared with the histological results for recurrence. Receiver operating characteristics curves analysis, McNemar's test and logistic regression using generalised estimating equations were used to compare the diagnostic accuracy of 18 F-FDG PET/CT and standard imaging of CT/MRI or chest CT, and a Cox proportional hazards model was used to assess the prognostic value of PET/CT. Results During a median follow-up of 44 months (range, 24–62 months), 73 patients (26.3%) had recurrence or persistent diseases. The area under curves for 18 F-FDG PET/CT and CT/MRI were 0.975 (0.964–0.992) and 0.789 (0.713–0.874), respectively ( P < 0.001). 18 F-FDG PET/CT detected 65 of 66 recurrences (98.5%) not suggested by physical examination and endoscopy. Positive findings on 18 F-FDG PET/CT scans were independent predictors of poorer cancer-specific and overall survival outcomes ( P < 0.01). Conclusions Posttreatment 18 F-FDG PET/CT surveillance helps to properly detect recurrence and to predict the survival following treatment of HNSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
8. Clinical values for abnormal 18F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
- Author
-
Lee, Hwan Seo, Kim, Jae Seung, Roh, Jong-Lyel, Choi, Seung-Ho, Nam, Soon Yuhl, and Kim, Sang Yoon
- Subjects
- *
CLINICAL trials , *GLUCOSE metabolism , *SQUAMOUS cell carcinoma , *HEAD & neck cancer , *POSITRON emission tomography , *COMPUTED tomography - Abstract
Highlights: [•] Abnormal 18F-FDG uptakes in the head and neck (HN) region can be carefully interpreted as being index primary, second primary cancer (SP) or benign. [•] 18F-FDG PET/CT identified 91.9% primary HN squamous cell carcinomas (HNSCC). [•] The specificity and negative predictive value of 18F-FDG PET/CT for identification of SP were as high as 98.7% and 99.3%, respectively. [•] Proper detection of primary tumors and SP in the HN region may promote appropriate therapeutic planning of HNSCC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
9. Utility of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma
- Author
-
Roh, Jong-Lyel, Yeo, Nam-Kyung, Kim, Jae Seung, Lee, Jeong Hyun, Cho, Kyung-Ja, Choi, Seung-Ho, Nam, Soon Yuhl, and Kim, Sang Yoon
- Subjects
- *
MEDICAL imaging systems , *POSITRON emission tomography , *CANCER patients , *SQUAMOUS cell carcinoma , *CANCER invasiveness - Abstract
Summary: The combination of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and computed tomography (CT) has been reported to be more accurate than CT or PET alone in a preoperative setting. We compared the diagnostic utility of preoperative PET/CT, PET and CT/MRI in 167 patients with newly diagnosed head and neck squamous cell carcinoma (HNSCC), of whom 104 underwent FDG PET and 63 underwent combined PET/CT with all receiving CT/MRI. These preoperative PET, PET/CT, and CT/MRI results were reviewed and their accuracies were compared in patients in whom diagnosis was confirmed histopathologically. Age, sex, primary sites and stage, and nodal involvement were comparable between two groups. The accuracy of PET and PET/CT for detecting primary tumors and cervical metastases was comparable, but significantly higher than that of CT/MRI (98%–97% vs. 86–88% for primary; 92%–93% vs. 85%–86% for neck on a level-by-level basis; P <.05). PET and PET/CT gave false negative results: in 2 (2%) and 2 (3%) patients for primary tumors; in 6 (6%) and 3 (5%) patients for neck metastases, respectively. PET and PET/CT also gave false-positive results for cervical metastases in 5 (5%) and 4 (6%) patients, respectively. Compared with PET alone, preoperative FDG PET/CT may not yield significantly improved diagnostic accuracy in patients with HNSCC. Moreover, despite their high accuracy, PET and PET/CT may not abrogate the need for conventional imaging and pathologic staging based on primary resection and neck dissection. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.